CEPICS A comparison and evaluation platform for integration methods in cancer subtyping

Introduction

CEPICS is a comprehensive evaluation and comparison platform for multi-omics data integration methods in cancer subtyping. Given a user-specified maximum number of subtypes, k-max, CEPICS provides (1) cancer subtyping results using up to five built-in state-of-the-art integration methods under the number of subtypes from two to k-max, (2) a report including the evaluation of each user-selected method and comparisons across them using clustering performance metrics and clinical survival analysis, and (3) an overall analysis of subtyping results by different methods representing a robust cancer subtype prediction for samples. Furthermore, users can upload subtyping results of their own methods to compare with the built-in methods.

Publications

  1. CEPICS: A Comparison and Evaluation Platform for Integration Methods in Cancer Subtyping
    Ran Duan, Lin Gao, Han Xu, Kuo Song, Yuxuan Hu, Hongda Wang, Yongqiang Dong, Chenxing Zhang, Songwei Jia, 2019/10/8 - Frontiers in Genetics

Credits

  1. Ran Duan duanran9013@126.com
    InvestigatorDeveloper

    School of Computer Science and Technology, Xidian University, China

  2. Lin Gao lgao@mail.xidian.edu.cn
    Investigator

    School of Computer Science and Technology, Xidian University, China

  3. Han Xu hxu10670@gmail.com
    DeveloperContributor

    School of Computer Science and Technology, Xidian University, China

  4. Song Kuo uysk@foxmail.com
    DeveloperContributor

    School of Computer Science and Technology, Xidian University, China

Community Ratings

UsabilityEfficiencyReliabilityRated By
0 user
Sign in to rate
Summary
AccessionBT007143
Tool TypeApplication
CategoryMulti-omic data integration
PlatformsLinux/Unix, MAC OS X, Windows
TechnologiesR
User InterfaceTerminal Command Line
Latest Release1.0.1 (May 31, 2021)
Download Count837
Country/RegionChina
Submitted ByLin Gao
Fundings

This work was supported by the National Key R&D Program of China No.2018YFC0910400.